|
1
|
Nguyen HM, Paulishak W, Oladejo M and Wood
L: Dynamic tumor microenvironment, molecular heterogeneity, and
distinct immunologic portrait of triple-negative breast cancer: An
impact on classification and treatment approaches. Breast Cancer.
30:167–186. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molinelli C, Jacobs F, Agostinetto E,
Nader-Marta G, Ceppi M, Bruzzone M, Blondeaux E, Schettini F, Prat
A, Viale G, et al: Prognostic value of HER2-low status in breast
cancer: A systematic review and meta-analysis. ESMO Open.
8:1015922023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qi X, Qiao B, Song T, Huang D, Zhang H,
Liu Y, Jin Q, Yang M and Liu D: Clinical utility of the
pan-immune-inflammation value in breast cancer patients. Front
Oncol. 13:12237862023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Chen S, Chen H and Li W: A
comprehensive analysis of Glasgow Prognostic Score (GPS)/the
modified Glasgow Prognostic Score (mGPS) on immune checkpoint
inhibitor efficacy among patients with advanced cancer. Cancer Med.
12:38–48. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang F, Wu Z, Sun S, Fu Y, Chen Y and Liu
J: POEMS syndrome in the 21st century: A bibliometric analysis.
Heliyon. 9:e206122023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Gao Y, Ying J, Yu H, Guo R, Xiong
J and Jiang H: Bibliometric analysis of global research on breast
reconstruction after mastectomy for breast cancer from 2011 to
2021. J Cosmet Dermatol. 22:2071–2082. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nie D, Zhang L, Wang C, Guo Q and Mao X: A
high Glasgow prognostic score (GPS) or modified Glasgow prognostic
score (mGPS) predicts poor prognosis in gynecologic cancers: A
systematic review and meta-analysis. Arch Gynecol Obstet.
301:1543–1551. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abbass T, Dolan RD, MacLeod N, Horgan PG,
Laird BJ and McMillan DC: Comparison of the prognostic value of
MUST, ECOG-PS, mGPS and CT derived body composition analysis in
patients with advanced lung cancer. Clin Nutr ESPEN. 40:349–356.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Z, Chen Y, Yu G and Ma Y: Research
trends and hotspots in surgical treatment of recurrent
nasopharyngeal carcinoma: A bibliometric analysis from 2000 to
2023. Asian J Surg. 47:2939–2941. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Jia L, Guo R, Xiong J and Jiang
H: A bibliometric and visualized study on global trends of breast
augmentation complications, 2011–2021. Gland Surg. 12:354–365.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boukovala M, Modest DP, Ricard I, Fischer
von Weikersthal L, Decker T, Vehling-Kaiser U, Uhlig J, Schenk M,
Freiberg-Richter J, Peuser B, et al: Evaluation of the
inflammation-based modified Glasgow Prognostic Score (mGPS) as a
prognostic and predictive biomarker in patients with metastatic
colorectal cancer receiving first-line chemotherapy: A post hoc
analysis of the randomized phase III XELAVIRI trial (AIO KRK0110).
ESMO Open. 9:1033742024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goktas Aydin S, Kutlu Y, Muglu H, Aydin A,
Acikgoz O, Hamdard J, Karci E, Bilici A, Olmez OF and Yildiz O:
Predictive significance of inflammatory markers and mGPS in
metastatic castration-resistant prostate cancer treated with
abiraterone or enzalutamide. Cancer Chemother Pharmacol. 93:71–78.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Wu Z, Pan Y, Chen Y, Chu J, Cong Y
and Fang Q: GNL3L exhibits pro-tumor activities via NF-κB pathway
as a poor prognostic factor in acute myeloid leukemia. J Cancer.
15:4072–4080. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang H, Tang S, Biskup E, Zhang Y, Yong
L, Chen L and Cai F: Long-term survival after diverse therapeutic
modalities in malignant phyllodes tumors of the breast. Technol
Cancer Res Treat. 21:153303382211210862022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu XY, Zhang X, Zhang Q, Ruan GT, Liu T,
Xie HL, Ge YZ, Song MM, Deng L and Shi HP: The value of
CRP-albumin-lymphocyte index (CALLY index) as a prognostic
biomarker in patients with non-small cell lung cancer. Support Care
Cancer. 31:5332023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di Castelnuovo A, Bonaccio M, Costanzo S,
De Curtis A, Magnacca S, Persichillo M, Panzera T, Bracone F,
Pignatelli P, Carnevale R, et al: The association between
hypoalbuminemia and risk of death due to cancer and vascular
disease in individuals aged 65 years and older: Findings from the
prospective Moli-sani cohort study. EClinicalMedicine.
72:1026272024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shapaer T, Chen Y, Pan Y, Wu Z, Tang T,
Zhao Z and Zeng X: Elevated BEAN1 expression correlates with poor
prognosis, immune evasion, and chemotherapy resistance in rectal
adenocarcinoma. Discov Oncol. 15:4462024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zou Y, Hu X and Deng X: Distant lymph node
metastases from breast cancer-Is it time to review TNM cancer
staging? JAMA Netw Open. 4:e2120262021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Veerla S, Hohmann L, Nacer DF,
Vallon-Christersson J and Staaf J: Perturbation and stability of
PAM50 subtyping in population-based primary invasive breast cancer.
NPJ Breast Cancer. 9:832023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Xia T, Xia Z, Zhou H, Li Z, Wang
W, Zhai X and Jin B: KIF18A inactivates hepatic stellate cells and
alleviates liver fibrosis through the TTC3/Akt/mTOR pathway. Cell
Mol Life Sci. 81:962024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao H, Yu L and Wang L, Yin X, Liu K, Liu
W, Lin S and Wang L: Integrated analysis of single-cell and bulk
RNA sequencing data reveals immune-related lncRNA-mRNA prognostic
signature in triple-negative breast cancer. Genes Dis. 11:571–574.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reyes-Ruiz A, Calvillo-Rodriguez KM,
Martínez-Torres AC and Rodríguez-Padilla C: The bovine dialysable
leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death
in breast cancer cells leading to long-term antitumour memory. Br J
Cancer. 124:1398–1410. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shayimu P, Awula M, Wang CY, Jiapaer R,
Pan YP, Wu ZM, Chen Y and Zhao ZL: Serum nutritional predictive
biomarkers and risk assessment for anastomotic leakage after
laparoscopic surgery in rectal cancer patients. World J
Gastrointest Surg. 16:3142–3154. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hua S, Wang W, Yao Z, Gu J, Zhang H, Zhu
J, Xie Z and Jiang H: The fatty acid-related gene signature
stratifies poor prognosis patients and characterizes TIME in
cutaneous melanoma. J Cancer Res Clin Oncol. 150:402024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park YR, Jee W, Park SM, Kim SW, Bae H,
Jung JH, Kim H, Kim S, Chung JS and Jang HJ: Viscum album induces
apoptosis by regulating STAT3 signaling pathway in breast cancer
cells. Int J Mol Sci. 24:119882023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hacker UT, Hasenclever D, Baber R, Linder
N, Busse H, Obermannova R, Zdrazilova-Dubska L, Valik D and Lordick
F: Modified Glasgow prognostic score (mGPS) is correlated with
sarcopenia and dominates the prognostic role of baseline body
composition parameters in advanced gastric and esophagogastric
junction cancer patients undergoing first-line treatment from the
phase III EXPAND trial. Ann Oncol. 33:685–692. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu Z, Chen Y, Jiang D, Pan Y, Tang T, Ma Y
and Shapaer T: Mitochondrial-related drug resistance lncRNAs as
prognostic biomarkers in laryngeal squamous cell carcinoma. Discov
Oncol. 15:7852024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma L, Gao P, Liu Z, Jiao D, Ling R, Xiao
J, Zhao Y, Wang Y, Yang H, Liu Y, et al: Association of a complete
breast cancer pathologic response with axillary lymph node
metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012
study. Chin Med J (Engl). 137:1369–1371. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dimitrakopoulos FI, Goussia A, Koliou GA,
Dadouli K, Batistatou A, Kourea HP, Bobos M, Arapantoni-Dadioti P,
Tzaida O, Koletsa T, et al: Ten-year clinical outcome, toxicity and
compliance of dose-dense sequential adjuvant administration of
cyclophosphamide & epirubicin followed by docetaxel in patients
with early breast cancer: A hellenic cooperative oncology group
observational study (HE 10/10) with concurrent investigation of
significance of tumor infiltrating lymphocytes. Breast.
73:1036682024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Proctor MJ, Talwar D, Balmar SM, O'Reilly
DS, Foulis AK, Horgan PG, Morrison DS and McMillan DC: The
relationship between the presence and site of cancer, an
inflammation-based prognostic score and biochemical parameters.
Initial results of the Glasgow Inflammation Outcome Study. Br J
Cancer. 103:870–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haq ATA, Yang PP, Jin C, Shih JH, Chen LM,
Tseng HY, Chen YA, Weng YS, Wang LH, Snyder MP, et al:
Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1
circuit prevent relapse and metastasis of triple-negative breast
cancer. Theranostics. 14:2167–2189. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Farhana A, Alsrhani A, Alghsham RS, Derafa
W, Khan YS and Rasheed Z: Gold nanoparticles downregulate IL-6
expression/production by upregulating microRNA-26a-5p and
deactivating the RelA and NF-κBp50 transcription pathways in
activated breast cancer cells. Int J Mol Sci. 25:14042024.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Y, Maitiniyazi G, Li Z, Li T, Liu Y,
Zhang R, Cao X, Gu D and Xia S: TNF-α mediates the association
between dietary inflammatory index and depressive symptoms in
breast cancer. Nutrients. 15:842022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruan GT, Xie HL, Hu CL, Liu CA, Zhang HY,
Zhang Q, Wang ZW, Zhang X, Ge YZ, Lin SQ, et al: Comprehensive
prognostic effects of systemic inflammation and Insulin resistance
in women with breast cancer with different BMI: A prospective
multicenter cohort. Sci Rep. 13:43032023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao W, Li M and Zhang Y:
Fibrinogen/albumin ratio (FAR) in patients with triple negative
breast cancer and its relationship with epidermal growth factor
receptor expression. Onco Targets Ther. 14:5403–5415. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiang M, Zhang H, Tian J, Yuan Y, Xu Z and
Chen J: Low serum albumin levels and high neutrophil counts are
predictive of a poorer prognosis in patients with metastatic breast
cancer. Oncol Lett. 24:4322022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang MD, Duan FF, Hua X, Cao L, Xia W and
Chen JY: A novel albumin-related nutrition biomarker predicts
breast cancer prognosis in neoadjuvant chemotherapy: A two-center
cohort study. Nutrients. 15:42922023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yin L, Duan JJ, Bian XW and Yu SC:
Triple-negative breast cancer molecular subtyping and treatment
progress. Breast Cancer Res. 22:612020. View Article : Google Scholar : PubMed/NCBI
|
